Metlife Inc [NYSE: MET] loss -1.04% or -0.71 points to close at $67.84 with a heavy trading volume of 5070805 shares. The company report on February 12, 2024 at 10:00 AM that MetLife Hires New Head of Data Enablement.
MetLife, Inc. (NYSE: MET) today announced that Michelleta (“Mich”) Razon will join the company as Head of Data Enablement. She will report to Robin Gordon, MetLife Chief Data and Analytics Officer.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In this role, Mich and her team will work directly with the businesses across MetLife’s 40+ markets driving alignment to enterprise data solutions and capabilities, resulting in an environment where data is readily accessible, well managed and used effectively to drive decision making and innovation.
The daily chart for MET points out that the company has recorded 6.72% gains over the past six months.
If we look at the average trading volume of 1.30 shares, MET reached to a volume of 5070805 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Metlife Inc [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $79.73 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 1.61. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Metlife Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2024.
The Average True Range (ATR) for Metlife Inc is set at 1.33, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.74. The Price to Book ratio for the last quarter was 1.97. Price to Free Cash Flow for MET in the course of the last twelve months was 5.27.
Trading performance analysis for MET stock
Metlife Inc [MET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.85. With this latest performance, MET shares dropped by -1.44% in over the last four-week period, additionally plugging by 6.72% over the last 6 months – not to mention a drop of -4.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 50.82, with the RSI for the last a single of trading hit 50.49, and the three-weeks RSI is set at 52.04 for Metlife Inc [MET]. The present Moving Average for the last 50 days of trading for this stock 67.13, while it was recorded at 67.53 for the last single week of trading, and 61.40 for the last 200 days.
Metlife Inc [MET]: A deeper dive into fundamental analysis
Metlife Inc’s liquidity data is similarly interesting compelling, with a Current Ratio set at 2.98.
Metlife Inc [MET]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Metlife Inc posted 1.52/share EPS, while the average EPS was predicted by analysts to be reported at 1.83/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -16.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Metlife Inc go to 11.50%.
An analysis of Institutional ownership at Metlife Inc [MET]
The top three institutional holders of MET stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in MET stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in MET stock with ownership which is approximately 5.8325%.
